Manufacturing depression (64 page)

Lin, E. H. B., M. Von Korff, W. Katon, T. Bush, G. E. Simon, E. Walker, and P. Robinson. “The Role of the Primary Care Physician in Patients’ Adherence to Antidepressant Therapy.”
Medical Care
33, no. 1 (1995): 67–74.

Lind, James.
A Treatise of the Scurvy.
Edinburgh: A. Kincaid & A. Donaldson, 1753.

———. “A Treatise of the Scurvy.” James Lind Library website. The Royal College of Physicians of Edinburgh. Available online at
http://www.jameslindlibrary.org/trial_records/17th_18th_Century/lind/lind_kp.html
.

Loewi, O.
From the Workshop of Discoveries
. Lawrence, KS: University of Kansas Press, 1953.

Loomer, H. P., J. C. Saunders, and N. S. Kline. “Iproniazid: an Amine-Oxidase Inhibitor, as an Example of a Psychic Energizer.”
Congressional Record
, 1957, pp. 1382–90.

Luborsky, Lester, Lisa Luborsky, and B. Singer. “Comparative Studies of Psychotherapies: Is It True That ‘Everyone Has Won and All Must Have Prizes’?”
Archives of General Psychiatry
32 (1975): 995–1008.

Luborsky, L., L. Diguer, D. A. Seligman, R. Rosenthal, E. D. Krause, S. Johnson, G. Halperin, M. Bishop, J. S. Berman, and E. Schweizer. “The Researcher’s Own Therapy Allegiances: A ‘Wild Card’ in Comparisons of Treatment Efficacy.”
Clinical Psychology: Science and Practice
6, no. 1 (1999): 95–106.

Lutz, T.
American Nervousness, 1903: An Anecdotal History.
Ithaca, NY: Cornell University Press, 1991.

Mackey, N. “Phrenological Whitman.”
Conjunctions,
Fall 1997. Available online at
www.conjunctions.com/archives/c29-nm.htm
.

Malber, J., and K. R. Bronson. “How MDMA Works in the Brain.” In
Ecstasy: The Complete Guide
, edited by J. Holland, 29–38. Rochester, VT: Park Street Press, 2001.

Mann, J.
Elusive Magic Bullet: The Search for the Perfect Drug.
Oxford: Oxford University Press, 1999.

Marks, H. M.
The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990.
Cambridge: Cambridge University Press, 2000.

Marquardt, M.
Paul Ehrlich.
New York: Schuman, 1951.

Martin, E. “Pharmaceutical Virtue.”
Culture, Medicine and Psychiatry
30 (2006): 157–74.

Martin, J. H. “Saints, Sinners, and Reformers: The Burned-Over District Revisited.”
Crooked Lake Review,
2005. Available online at
www.crookedlakereview.com/books/saints_sinners/martin12.html
.

Marwit, S. J. “Reliability of Diagnosing Complicated Grief: A Preliminary Investigation.”
Journal of Clinical and Consulting Psychiatry
64, no. 3 (1996): 563–68.

Massachusetts General Hospital. “Safety and Effectiveness of Omega-3 Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression.” ClinicalTrials.gov website, U.S. National Institutes of Health. 2006–2009. Available online at
http://www.clinicaltrials.gov/ct2/show/NCT00361374?term=major+depression+Omega&rank=1
.

Menninger, K.
The Vital Balance.
New York: Viking, 1963.

Menninger, W. “Psychiatric Experience in the War, 1941–1946.”
American Journal of Psychiatry
103, no. 5 (March 1947): 577–86.

Meyer, A.
The Commonsense Psychiatry of Dr. Adolf Meyer,
edited by Alfred Lief. New York: McGraw Hill, 1948.

———. “The ‘Complaint’ as the Center of Genetic-Dynamic and Nosological Teaching in Psychiatry.”
New England Journal of Medicine
199, no. 8 (1928): 360–70.

———. “A Few Demonstrations of the Pathology of the Brain.”
American Journal of Insanity
52 (1895): 238–45.

———. “Presidential Address: Twenty-Five Years of Psychiatry in the United States and Our Present Outlook.”
American Journal of Psychiatry
8 (July 1928): 1–31.

Mintz, M. “‘Heroine’ of FDA Keeps Bad Drug off Market.”
Washington Post
, July 15, 1962: p. A1.

Monfils, Paul. “Murex Shells Used to Produce Dye.” Man and Mollusc website, edited by Avril Bourquin. Available online at
http://www.manandmollusc.net/Shell_photos/dye-murex.html
.

“Morgan’s Old Gold.”
Time,
May 28, 1928. Available online at
http://www.time.com/time/magazine/article/0,9171,786005,00.html
.

Multidisciplinary Association for Psychedelic Studies website. Available online at
www.maps.org
.

Narrow, W. E., D. S. Rae, L. N. Robins, and D. A. Regier. “Revised Prevalence Estimates of Mental Disorders in the United States: Using a Clinical Significance Criterion to Reconcile 2 Surveys’ Estimates.”
Archives of General Psychiatry
59, no. 2 (2002): 115–30.

National Institute of Mental Health. “Drug Therapy to Treat Minor Depression.” Clinicaltrials.gov website, U.S. National Institutes of Health, 2002–2009. Available online at
http://www.clinicaltrials.gov/ct2/show/NCT00048815?term=minor+depression&rank=1
.

National Institutes of Health.
www.ClinicalTrials.gov
.

Neslin, Scott. “Executive Summary: ROI Analysis of Pharmaceutical Promotion.” RxPromoROI website. Available online at
www.rxpromoroi.org/rapp/exec_sum.html
.

———. “RAPP Study.” RxPromorROI website, 2002. Available online at
http://www.rxpromoroi.org/rapp/index.html
.

New York Times.
“American Loses Suit against Freud.” May 25, 1927.

———. “City Agents Hunt Supplies of Drug.” April 12, 1958, p. 1.

———. “Death of Woman Laid to ‘Pep Pills.’” April 11, 1958.

———. “Dr. Sakel Is Dead; Psychiatrist, 57.” Dec. 3, 1957.

———. “Physician Warns on Wonder Drugs.” April 13, 1960.

———. “Warns of Danger in American Life.” June 5, 1927.

Nuland, S.
Doctors: The Biography of Medicine.
New York: Knopf, 1988.

Nurnberg, H. G., P. L. Hensley, J. R. Heiman, H. A. Croft, C. DeBattista, and S. Paine. “Sildenafil Treatment of Women with Antidepressant-Associated Sexual Dysfunction: A Randomized Controlled Trial.”
JAMA
300, no. 4 (2008): 395–404.

Office of National Drug Control Policy. “National Drug Control Strategy, FY 2009 Budget Summary.” Executive Summary. Available online at
http://www.whitehousedrugpolicy.gov/publications/policy/09budget/exec_summ.pdf
.

Olfsun, M., and S. Marcus. “National Patterns in Antidepressant Medication Treatment.”
Archives of General Psychiatry
66, No. 8 (2009): 848–56.

Parens, E. “Kramer’s Anxiety.” In
Prozac as a Way of Life
, edited by C. Elliott and T. Chambers, 21–32. Chapel Hill, NC: University of North Carolina Press, 2004.

Parker, G., and K. Fletcher. “Treating Depression with the Evidence-Based Psychotherapies: A Critique of the Evidence.”
Acta Psychiatrica Scandinavica
115 (2007): 352–59.

Peale, Norman Vincent.
The Power of Positive Thinking.
New York: Fawcett Columbine, 1966.

Pearce, J. M. S. “Leopold Auenbrugger: Camphor-Induced Epilepsy—Remedy for Manic Psychosis.”
European Neurology
59 (2008): 105–7.

Pfizer. “Myths and Facts about Depression.” Zoloft (Sertraline HCI) website, 2008. Available online at
http://www.zoloft.com/depr_myths_facts.aspx
.

“Pharmacy Facts and Figures.” Drug Topics website. Available online at
http://drugtopics.modernmedicine.com/drugtopics/article/articleList.jsp?categoryId=7604
.

Pliny. [Gaius Plinius Secundus],
Natural History: A Selection.
London: Penguin Classics, 1991.

Popper, K.
The Poverty of Historicism.
New York: Harper & Row, 1957.

Popper, K. R., and J. C. Eccles.
The Mind and Its Brain: An Argument for Interactionism.
London: Routledge & Kegan Paul, 1977.

Preston, S. D., and F. B. de Waal. “Empathy: Its Ultimate and Proximate Bases.”
The Behavioral and Brain Sciences
25 (2002): 1–20.

“Prontosil.”
Time,
December 28, 1936.

Quetel, C.
History of Syphilis,
translated by J. Braddock and B. Pike. Baltimore, MD: Johns Hopkins University Press, 1992.

Reader’s Digest.
“Depression Hurts: Prozac Can Help.” Advertisement. May 1998, pp. 182–84.

Regier, D. A. “State-of-the-Art Psychiatric Diagnosis.”
World Psychiatry
3, no. 1 (2004): 25–26.

“Relieves Anxiety and Anxious Depression.” Miltown advertisement.
Archives of General Psychiatry
8, no. 2 (1963), following p. 135.

Richardson, R. D.
William James: In the Maelstrom of American Modernism.
Boston: Houghton Mifflin, 2006.

Richeson, J. S., A. A. Baird, H. L. Gordon, T. F. Heatherton, C. L. Wyland, S. Trawalter, and J. N. Shelton. “An fMRI Investigation of the Impact of Interracial Contact on Executive Function.”
Nature Neuroscience
6, no. 12 (2003): 1323–28.

Rinkel, M., H. J. DeShon, and H. C. Solomon. “Experimental Schizophrenia-like Symptoms.”
American Journal of Psychiatry
108 (1952): 572–78.

Rinkel, M., R. W. Hyde, H. C. Solomon, and H. Hoagland. “Experimental Psychiatry II: Clinical and Physio-chemical Observations in Experimental Psychoses.”
American Journal of Psychiatry
111, no. 12 (1955): 881–95.

Robinson, L. A., J. S. Berman, and R. A. Neimeyer. “Psychotherapy for the Treatment of Depression: A Comprehensive Review of Controlled Outcome Research.”
Psychological Bulletin
108 (1990): 30–49.

Roccatagliata, G.
A History of Ancient Psychiatry.
Santa Barbara, CA: Greenwood Press, 1986.

Rosenhan, D. “On Being Sane in Insane Places.”
Science
179, no. 70 (Jan. 1973): 250–58.

Rosenzweig, S. “Some Implicit Common Factors in Diverse Methods of Psychotherapy.”
American Journal of Ortho-psychiatry
6 (1936): 412–15.

Rush, A. J., A. T. Beck, M. Koracs, and S. Hollon. “Comparative Efficacy of Cognitive Therapy and Pharmacotherapy in the Treatment of Depressed Outpatients.”
Cognitive Therapy and Research
1, no. 1 (1977): 17–37.

Rusk, H. A. “Drugs and Depression.”
New York Times
, September 6, 1959.

RxPromoROI: A Resource for Pharmaceutical Promotion ROI Results website. Available at
www.rxpromoroi.org
.

Sakel, M. “The Methodical Use of Hypoglycemia in the Treatment of Psychoses.”
American Journal of Psychiatry
94 (1937): 111–29.

———.
Schizophrenia.
New York: Philosophical Library, 1958.

Sandifer, M. G., A. Hordern, G. C. Timbury, and L. M. Green. “Psychiatric Diagnosis: A Comparative Study in North Carolina, London, and Glasgow.”
British Journal of Psychiatry
114 (1968): 1–9.

Schildkraut, J. “The Catecholamine Hypothesis of Affective Disorders.”
American Journal of Psychiatry
122 (1965): 509–22.